StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Integra LifeSciences's price to book ratio was 1.1× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.6× to 3.5×, with a median of 1.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×+0.2
2025Dec 31, 20250.9×−0.2
2024Dec 31, 20241.2×−1.1
2023Dec 29, 20232.3×−0.5
2022Dec 30, 20222.7×−0.8
2021Dec 31, 20213.5×−0.5
2020Dec 31, 20204.0×+0.3
2019Dec 31, 20193.6×+0.9
2018Dec 31, 20182.7×−1.4
2017Dec 29, 20174.2×−0.0
2016Dec 30, 20164.2×+1.0
2015Dec 31, 20153.2×+0.8
2014Dec 31, 20142.3×−0.1
2013Dec 31, 20132.4×+0.5
2012Dec 31, 20121.9×+0.3
2011Dec 30, 20111.7×−1.1
2010Dec 31, 20102.7×+0.2
2009Dec 31, 20092.5×–

More Integra LifeSciences figures

See a number that looks wrong?